臨床眼科64巻6号

2010年06月発行

連載 今月の話題

黄斑浮腫の治療

著者： 志村雅彦¹

所属機関： ¹NTT東日本東北病院眼科

ページ範囲：P.827 - P.835

　黄斑浮腫は実に厄介な病気である。神経細胞が密集し，多くの血流を必要としながら血管の存在しない網膜黄斑部に水分が異常貯留するのである。原因疾患は多種多彩であり，病態も明らかにされていない。にもかかわらず，硝子体手術や網膜光凝固，抗炎症ステロイドや抗VEGF抗体の投与など，病態の解明に先立って治療が行われており，しかもそれなりに満足のいく効果が得られている。本稿では，現状における黄斑浮腫治療を総括するとともに，そこからみえる黄斑浮腫の病態について論じてみたい。

参考文献

1）Early Treatment Diabetic Retinopathy Study research group：Photocoagulation for diabetic macular edema. ETDRS report number 1. Arch Ophthalmol　103：1796-1806, 1985

2）Browning DJ, Altaweel MM, Bressler NM et al：Diabetic macular edema. What is focal and what is diffuse? Am J Ophthalmol　146：649-655, 2008

3）Fine BS, Brucker AJ：Macular edema and cystoid macular edema. Am J Ophthalmol　92：466-481, 1981

4）Otani T, Kishi S：Correlation between optical coherence tomography and fluorescein angiography findings in diabetic macular edema. Ophthalmology　114：104-107, 2007

5）Kim BY, Smith SD, Kaiser PK：Optical coherence tomographic patterns of diabetic macular edema. Am J Ophthalmol　142：405-412, 2006

6）Otani T, Kishi S：Tomographic assessment of vitreous surgery for diabetic macular edema. Am J Ophthalmol　129：487-494, 2000

7）Wallow IH：Repair of the pigment epithelial barrier following photocoagulation. Arch Ophthalmol　102：126-135, 1984

8）Bresnick GH：Diabetic maculopathy, a critical review highlighting diffuse macular edema. Ophthalmology　90：1301-1317, 1983

9）Sinclair SH, Alaniz R, Presti P：Laser treatment of diabetic macular edema：comparison of ETDRS-level treatment with threshold-level treatment by using high-contrast discriminant central visual field testing. Semin Ophthalmol　14：214-222, 1999

10）Shimura M, Yasuda K, Nakazawa T et al：Effective treatment of diffuse diabetic macular edema by temporal grid pattern photocoagulation. Ophthalmic Surg Lasers　35：270-280, 2004

11）Kang SW, Sa HS, Cho HY et al：Macular grid photocoagulation after intravitreal triamcinolone acetonide for diffuse diabetic macular edema. Arch Ophthalmol　124：653-658, 2006

12）Shimura M, Nakazawa T, Yasuda K et al：Pretreatment of posterior subtenon injection of triamcinolone acetonide has beneficial effects for grid pattern photocoagulation against diffuse diabetic macular edema. Br J Ophthalmol　91：449-454, 2007

13）Funatsu H, Yamashita H, Ikeda T et al：Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema. Ophthalmology　110：1690-1696, 2003

14）Noma H, Funatsu H, Mimura T et al：Vitreous levels of interleukin-6 and vascular endothelial growth factor in macular edema with central retinal vein occlusion. Ophthalmology　116：87-93, 2009

15）Stefansson E：Physiology of vitreous surgery. Graefes Arch Clin Exp Ophthalmol　247：147-163, 2009

16）Cunningham MA, Edelman JL, Kaushal S：Intravitreal steroids for macular edema：the past, the present, and the future. Surv Ophthalmol　53：139-149, 2008

channels. Am J Physiol Lung Cell Mol Physiol　293：L1332-L1338, 2007

18）Zhang X, Bao S, Lai D et al：Intravitreal triamcinolone acetonide inhibits breakdown of the blood-retinal barrier through differential regulation of VEGF-A and its receptors in early diabetic rat retinas. Diabetes　57：1026-1033, 2008

19）Shimura M, Yasuda K, Nakazawa T et al：Drug reflux during posterior subtenon infusion of triamcinolone acetonide in diffuse diabetic macular edema not only brings insufficient reduction but also causes elevation of intraocular pressure. Graefes Arch Clin Exp Ophthalmol　247：907-912, 2009

20）Lohela M, Bry M, Tammela T et al：VEGFs and receptors involved in angiogenesis versus lymphangio-genesis. Curr Opin Cell Biol　21：154-165, 2009

21）Stewart MW：Predicted biologic activity of intravitreal bevacizumab. Retina　27：1196-2000, 2007

22）Shimura M, Yasuda K：Macular ischemia after intravitreal bevacizumab injection in patients with central retinal vein occlusion and a history of diabetes and vascular disease. Br J Ophthalmol　94：381-383, 2010

23）Diabetic Retinopathy Clinical Research Network：A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema. Ophthalmology　115：1447-1459, 2008

24）Shimura M, Nakazawa T, Yasuda K et al：Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema. Am J Ophthalmol　145：854-861, 2008

25）The Branch Retinal Vein Occlusion Study Group：Argon laser photocoagulation for macular edema in branch retinal vein occlusion. Am J Ophthalmol　98：271-282, 1984

26）The Central Retinal Vein Occlusion Study Group M report：Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. Ophthalmology　102：1425-1433, 1995

27）Opremcak EM, Bruce RA, Lomeo MD et al：Radial optic neurotomy for central retinal vein occlusion：a retrospective pilot study of 11 consecutive cases. Retina　21：408-415, 2001

28）Osterloh MD, Charles S：Surgical decompression of branch retinal vein occlusions. Arch Ophthalmol　106：1469-1471, 1988

29）Weiss JN, Bynoe LA：Injection of tissue plasminogen activator into a branch retinal vein in eyes with central retinal vein occlusion. Ophthalmology　108：2249-2257, 2001

30）Ghazi NG, Noureddine B, Haddad RS et al：Intravitreal tissue plasminogen activator in the management of central retinal vein occlusion. Retina　23：780-784, 2003

31）Cekic O, Chang S, Tseng JJ et al：Intravitreal triamcinlone injection for treatment of macular edema secondary to branch retinal vein occlusion. Retina　25：851-866, 2005

32）Kondo M, Kondo N, Ito Y et al：Intravitreal injection of bevacizumab for macular edema secondary to branch retinal vein occlusion. Retina　29：1242-1248, 2009